Personal care company Edgewell Personal Care (NYSE:EPC) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 2.1% year on year to $478.4 million. Its non-GAAP profit of $0.07 per share was 41.5% below analysts’ consensus estimates.
Is now the time to buy Edgewell Personal Care? Find out in our full research report .
Edgewell Personal Care (EPC) Q4 CY2024 Highlights:
Company Overview
Boasting brands such as Banana Boat, Schick, and Skintimate, Edgewell Personal Care (NYSE:EPC) sells personal care products in the skin and sun care, shave, and feminine care categories.
Personal Care
While personal care products products may seem more discretionary than food, consumers tend to maintain or even boost their spending on the category during tough times. This phenomenon is known as "the lipstick effect" by economists, which states that consumers still want some semblance of affordable luxuries like beauty and wellness when the economy is sputtering. Consumer tastes are constantly changing, and personal care companies are currently responding to the public’s increased desire for ethically produced goods by featuring natural ingredients in their products.
Sales Growth
Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can have short-term success, but a top-tier one grows for years.
With $2.24 billion in revenue over the past 12 months, Edgewell Personal Care is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage.
As you can see below, Edgewell Personal Care’s sales grew at a sluggish 2.2% compounded annual growth rate over the last three years. This shows it failed to generate demand in any major way and is a rough starting point for our analysis.
This quarter, Edgewell Personal Care reported a rather uninspiring 2.1% year-on-year revenue decline to $478.4 million of revenue, in line with Wall Street’s estimates.
Looking ahead, sell-side analysts expect revenue to grow 2% over the next 12 months, similar to its three-year rate. This projection doesn't excite us and suggests its newer products will not accelerate its top-line performance yet.
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. .
Organic Revenue Growth
When analyzing revenue growth, we care most about organic revenue growth. This metric captures a business’s performance excluding one-time events such as mergers, acquisitions, and divestitures as well as foreign currency fluctuations.
The demand for Edgewell Personal Care’s products has been stable over the last eight quarters but fell behind the broader sector. On average, the company has posted feeble year-on-year organic revenue growth of 2.5%.
In the latest quarter, Edgewell Personal Care’s organic sales fell by 1.3% year on year. This decline was a reversal from its historical levels. We’ll keep a close eye on the company to see if this turns into a longer-term trend.
Key Takeaways from Edgewell Personal Care’s Q4 Results
It was encouraging to see Edgewell Personal Care beat analysts’ organic revenue expectations this quarter. We were also happy its gross margin narrowly outperformed Wall Street’s estimates. The company also reiterated its previously-provided EPS guidance, showing that it remains on track. The stock traded up 7.7% to $34.01 immediately following the results.
Should you buy the stock or not? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it’s free .
